WESTSIDE INVESTMENT MANAGEMENT, INC. – CRISPR Therapeutics AG Transaction History
WESTSIDE INVESTMENT MANAGEMENT, INC. portfolio value:
$43.59M
portfolio value
WESTSIDE INVESTMENT MANAGEMENT, INC. quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -495K | $65.35 | 7.73K | |
| Q2 2022 | share | Decrease | -2.52% | -200 shares | -27K | $60.77 | 7.73K |
| Q1 2022 | share | Increase | +3.52% | 270 shares | 162K | $62.77 | 7.93K |
| Q4 2021 | share | Increase | +104.27% | 3.91K shares | 174K | $78.85 | 7.66K |
| Q3 2021 | share | Increase | +28.87% | 840 shares | 4.49M | $111.93 | 3.75K |
| Q2 2021 | share | Increase | +3.56% | 100 shares | 9.72M | $161.89 | 2.91K |
| Q1 2021 | share | Increase | +836.67% | 2.51K shares | -1.08M | $121.85 | 2.81K |
| Q4 2020 | share | Decrease | -25.00% | -100 shares | 5.53M | $153.11 | 300 |
| Q3 2020 | share | Decrease | -34.64% | -212 shares | 3.03M | $83.64 | 400 |
| Q2 2020 | share | Decrease | -29.00% | -250 shares | -3.38M | $73.49 | 612 |
| Q1 2020 | share | Increase | +762.00% | 762 shares | 25.45M | $42.41 | 862 |
| Q2 2019 | share | 0.00% | 0 shares | 1.14K | $47.1 | 100 | |
| Q4 2018 | share | 0.00% | 0 shares | -1.37K | $28.57 | 100 | |
| Q3 2018 | share | 0.00% | 0 shares | -1.77K | $44.35 | 100 | |
| Q2 2018 | share | Increase | 0.00% | 100 shares | 6.00K | $58.76 | 100 |
| Q1 2018 | share | Decrease | -100.00% | -100 shares | -2.60K | $45.71 | 0 |
| Q4 2017 | share | 0.00% | 0 shares | 637 | $23.48 | 100 | |
| Q3 2017 | share | 0.00% | 0 shares | 367 | $17.87 | 100 | |
| Q2 2017 | share | 0.00% | 0 shares | -382 | $16.02 | 100 | |
| Q1 2017 | share | Increase | 0.00% | 100 shares | 1.98K | $21.77 | 100 |